Korro Bio's OPERA platform offers precise RNA editing for genetic diseases like Alpha-1 antitrypsin deficiency. Learn more on ...

In the microscopic world of bacteria, gene transfer is a powerful mechanism that can alter cellular function, drive antibiotic resistance and even shape entire ecosystems. Now an interdisciplinary ...

RNA biology and its applications has been identified as a rapidly expanding field of critical importance to Singapore's ...

In a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac ...

The European Patent Office declared a patent owned by CureVac , valid, after a challenge from drugmaker BioNTech , the company said on Thursday.

Image: NIRBA will engage scientists and clinicians from leading institutions like NUS, A*STAR, NTU, and Duke-NUS Medical School, to build strategic ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

This study provides a potentially useful investigation into the positive role of BDNF/TrkB signaling in implanted dental pulp stem cells to enhance dentin regeneration in the context of dental caries.

Q4 2024 Earnings Call Transcript March 26, 2025 Dyadic International, Inc. misses on earnings expectations. Reported EPS is $ ...

R&D Expenses: Research and development expenses for the year ended December 31, 2024 decreased to approximately $2,044,000 ...

Learn more about whether Alvotech or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...